InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-14.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Kamdar Kim P.. Officer active across 4 companies, notably Singular Genomics Systems, Inc.. Aggregated, 8 reports have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €211k. Activity tracked since 18 June 2021. The latest transaction was filed on 6 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations8 total
15,000 sharesCommon StockSEC:0000950170-25-027096:0
7,117 shares0Class A Common StockSEC:0001534969-24-000133:0
10 shares@ US$0.621100.0% of flowCommon StockSEC:0001493152-23-045912:0
353,657 shares@ US$0.5955100.0% of flowCommon StockSEC:0001209191-23-045925:0
10,000 shares@ US$1.16550.0% of flowCommon StockSEC:0001618835-21-000156
Ideal exit: 15 Mar 2022 (T+270)
10,000 shares@ US$1.1651.14% mcap50.0% of flowCommon StockSEC:0001618835-21-000156:0
Ideal exit: 15 Mar 2022 (T+270)
4,395,633 sharesCommon StockSEC:0000904454-21-000498:0
4,395,633 sharesCommon StockSEC:0000904454-21-000498
8 of 8 declarations
